HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanovesicle aerosols as surfactant therapy in lung injury.

Abstract
Acute lung injury causes inactivation of pulmonary surfactant due to leakage of albumin and other markers. Current surfactants are ineffective in this condition and are instilled intratracheally. Nanovesicles of 300 ± 50 nm composed of nonlamellar phospholipids were developed as pulmonary surfactant aerosols for therapy in acid-induced lung injury. A combination of dipalmitoyl phosphatidylcholine and dioleoyl phosphatidylethanolamine was used. The size and composition of the nanovesicles were optimized for an improved airway patency in the presence of albumin and serum. In an acid-induced lung injury model in mice, on treatment with nanovesicle aerosols at a dose of 200 mg/kg, the alveolar protein leakage decreased from 8.62 ± 0.97 μg/mL to 1.94 ± 0.74 μg/mL, whereas the airway patency of the bronchoalveolar lavage fluid increased from 0.6 ± 0.0% to 91.7 ± 1.05%. Nanovesicle aerosols of nonlamellar lipids improved the resistance of pulmonary surfactants to inhibition and were promising as a noninvasive aerosol therapy in acute lung injury.
FROM THE CLINICAL EDITOR:
In acute lung injury, intrinsic surfactants are inactivated via albumin leakage and other mechanisms. Currently existing intratracheal surfactants are ineffective in this condition. The authors demonstrate that novel nanovesicle aerosols of nonlamellar lipids improved the resistance of pulmonary surfactants to inhibition and are promising as a noninvasive aerosol therapy in acute lung injury.
AuthorsAnubhav S Kaviratna, R Banerjee
JournalNanomedicine : nanotechnology, biology, and medicine (Nanomedicine) Vol. 8 Issue 5 Pg. 665-72 (Jul 2012) ISSN: 1549-9642 [Electronic] United States
PMID21889480 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Aerosols
  • Drug Carriers
  • Phosphatidylethanolamines
  • Surface-Active Agents
  • dioleoyl phosphatidylethanolamine
  • 1,2-Dipalmitoylphosphatidylcholine
Topics
  • 1,2-Dipalmitoylphosphatidylcholine (administration & dosage, chemistry)
  • Acute Lung Injury (chemically induced, drug therapy)
  • Aerosols (chemistry)
  • Animals
  • Bronchoalveolar Lavage Fluid (chemistry)
  • Cell Line, Tumor
  • Drug Carriers (chemistry)
  • Humans
  • Mice
  • Nanoparticles (chemistry)
  • Phosphatidylethanolamines (administration & dosage, chemistry)
  • Surface-Active Agents (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: